LRMR
Larimar Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.13
-0.07 (-2.19%)
Rating:C+
Company Profile
CEO
Carole S. Ben-Maimon
IPO Date
2014-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.12
Prev. Close
$3.20
Day Low
$3.10
Day High
$3.21
52W Low
$2.71
52W High
$6.42
Market Cap
$0.27B
Volume
0.38M